ARTICLE
15 August 2023

Purdue Pharma Ruling By U.S. Court Of Appeals For The Second Circuit: Not The Last Word

SR
Schulte Roth & Zabel LLP

Contributor

With a firm focus on private capital, Schulte Roth & Zabel comprises legal advisers and commercial problem-solvers who combine exceptional experience, industry insight, integrated intelligence and commercial creativity to help clients raise and invest assets and protect and expand their businesses.
In his recent article for Pratt's Journal of Bankruptcy Law titled "Purdue Pharma Ruling by U.S. Court of Appeals for the Second Circuit: Not the Last Word," Schulte Roth & Zabel of counsel Michael L. Cook discusses...
United States Litigation, Mediation & Arbitration
To print this article, all you need is to be registered or login on Mondaq.com.

In his recent article for Pratt's Journal of Bankruptcy Lawtitled "Purdue Pharma Ruling by U.S. Court of Appeals for the Second Circuit: Not the Last Word," Schulte Roth & Zabel of counsel Michael L. Cook discusses the U.S. Court of Appeals for the Second Circuit's recent decision regarding the nonconsensual releases of direct claims against third-party non-debtors in a Chapter 11 reorganization plan.

The U.S. Court of Appeals for the Second Circuit, in In re Purdue Pharma L.P., recently affirmed a bankruptcy court's confirmation of a reorganization plan with nonconsensual releases of direct claims against third-party non-debtors, the debtor's controlling owners.

Reversing the forceful opinion of the district court in In re Purdue Pharma L.P., the Second Circuit held that releases of direct claims are permitted under both Bankruptcy Code Sections 105 (a) and 1123(b)(6) and under "this Court's case law."

One judge on the three-judge panel, though, "reluctantly" concurred with the majority's holding only because of "binding" Second Circuit precedent, citing In re Drexel Burnham Lambert Group, Inc.

To view the full article, click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
15 August 2023

Purdue Pharma Ruling By U.S. Court Of Appeals For The Second Circuit: Not The Last Word

United States Litigation, Mediation & Arbitration

Contributor

With a firm focus on private capital, Schulte Roth & Zabel comprises legal advisers and commercial problem-solvers who combine exceptional experience, industry insight, integrated intelligence and commercial creativity to help clients raise and invest assets and protect and expand their businesses.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More